首页|粪便SDC2基因甲基化检测在广州市增城区居民结直肠癌筛查的应用研究

粪便SDC2基因甲基化检测在广州市增城区居民结直肠癌筛查的应用研究

扫码查看
目的 探讨粪便黏结蛋白聚糖2(Syndecan-2,SDC2)基因甲基化(methylated SDC2,mSDC2)检测在广州市城镇地区居民结直肠癌筛查的应用.方法 采用横断面研究方法,于2022年7-12月期间,针对广州市增城区石滩镇40~74岁常住居民展开结直肠癌社区筛查.筛查人群直接进行粪便mSDC2检测,对初筛阳性者建议其接受肠镜复查,对肠镜异常者建议接受进一步治疗.观察mSDC2检测初筛的阳性率、肠镜依从率、肠道病变检出率及其临床病理特征;同时探究mSDC2检测的CT值与肠道病变恶性程度的预测关系,评估筛查成本效益.结果 共计发放粪便采集装置8 877份,实际回收粪便样本8 189份,样本回收率92.25%,合格样本8048份,样本合格率98.28%.筛查对象中,男性3 182例(39.54%),女性4 866例(60.46%),年龄范围为40~74岁、平均年龄56岁.mSDC2初筛阳性率7.99%(643/8 048),肠镜依从率73.10%(470/643),470例完成肠镜检查的居民中,通过病理诊断发现结直肠癌20例(4.25%),进展期腺瘤109例(23.19%),非进展期腺瘤145例(30.85%),息肉79例(16.81%),整体肠道病变检出353例,肠道病变检出率75.11%.肠道病变检出率在男性中高于女性(x2=19.200,P<0.001),各年龄组间肠道病变检出率具有明显差异,且与年龄增长呈正相关(x2=18.200,P<0.001).检出的20例结直肠癌术后病理分期为0~I期15例,Ⅱ~Ⅲ期4例,未知分期1例.mSDC2检测结果CT值与进展期肿瘤的比例呈负相关,差异具有统计学意义(x2=16.063,P<0.001).本次筛查总成本433.95万元,筛查效益2 850.62万元,效益成本比6.57.结论 粪便mSDC2检测初筛结合肠镜精筛的结直肠癌筛查模式,具有较高的肠镜依从性和肠道病变检出率,有利于发现早期结直肠癌,具有良好的成本经济效益.粪便mSDC2检测CT值与肠道肿瘤的恶性程度可能具有相关性.
Study on the application value of fecal SDC2 gene methylation detection in colorectal cancer screening of urban residents in Zengcheng District in Guangzhou City
Objective To investigate the application value of fecal Syndecan-2(SDC2)gene methylated SDC2(mSDC2)detection in colorectal cancer(CRC)screening among urban residents in Guangzhou City.Methods A cross-sectional study was conducted in Shitan Town,Zengcheng District,Guangzhou City from July to December 2022.A community-based screening program for CRC was conducted among residents aged 40-74 years old.mSDC2 detection was employed in the participants,and those with positive results should be recommended to receive colonoscopy examination.The positive rate of mSDC2 detection,colonoscopy compliance rate,detection rate of intestinal lesions and clinicopathological characteristics were observed.The relationship between cycle threshold(CT)value of mSDC2 and intestinal lesions was explored.Further,the cost-effectiveness of screening was evaluated.Results A total of 8 189 fecal samples were collected from 8 877 participants with the recovery rate of 92.25%.8 048 qualified samples were enrolled in this study,consisted of 3 182 males(39.54%)and 4 866 females(60.46%),with the average age of 56 years old(40-74 years).The positive rate of mSDC2 detection was 7.99%(643/8 048),and the compliance rate of colonoscopy was 73.10%(470/643).20 cases(4.25%)of colorectal cancer,109 cases(23.19%)of advanced adenoma,145 cases(30.85%)of non-advanced adenoma,79 cases(16.81%)of polyps were detected.The detection rate of intestinal lesions was 75.11%and indicated significant differences in gender and age.20 CRCs included 15 of stage 0-1,4 of stage Ⅱ-Ⅲ and 1 of unknown stage.The CT value of mSDC2 was negatively correlated with the proportion of advanced colorectal neoplasms(x2=16.063,P<0.001).The total cost of the screening was 4.339 5 million yuan,the screening benefit was 28.506 2 million yuan,and the benefit-cost ratio was 6.57.Conclusion The CRC screening strategy of fecal mSDC2 detection combined with colonoscopy has high colonoscopy compliance and detection rate of intestinal lesions,which is conducive to the detection of early CRCs,and has good cost-effectiveness.This study suggests that this method may be applied to the general CRC screening in China and contribute to the prevention of CRC.The CT value of mSDC2 may have a certain suggestion on the malignant degree of intestinal tumors.

Colorectal cancer screeningFecal SDC2 gene methylationCost-effectiveness analysis

何滟、徐方芳、左海军、陈伟、刘志彬、刘泽帮、陈雪珍、惠庆申、邹耿文、蔡榛彬、刘扬、谭浩顺、周宏锋、汪建平

展开 >

前海人寿广州总医院结直肠肛门外科,广州 511330

前海人寿广州总医院健康管理中心,广州 511330

前海人寿广州总医院内镜中心,广州 511330

广州市增城区石滩镇人民政府,广州 511330

广州市增城区石滩镇公共卫生委员会办公室,广州 511330

中国医科大学肿瘤科,沈阳 110001

中山大学附属第六医院结直肠外科,广州 510630

展开 >

结直肠癌筛查 粪便SDC2基因甲基化 成本-效益分析

广东省卫济医学发展基金项目

K-202207-2

2024

中华预防医学杂志
中华医学会

中华预防医学杂志

CSTPCD北大核心
影响因子:1.652
ISSN:0253-9624
年,卷(期):2024.58(7)
  • 19